Sunil Verma, MD, MSEd, FRCPC
Articles
Dr. Verma on Palbociclib Plus Fulvestrant for HR+/HER2- Breast Cancer
July 20, 2015
Article
Sunil Verma, MD, MSEd, FRCPC, discusses the PALOMA-3 trial, which examined palbociclib with or without fulvestrant for the treatment of patients with HR-positive, HER2-negative breast cancer.
Advertisement
Advertisement